Varubi is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Tersera Therapeutics Llc. The primary component is Rolapitant Hydrochloride.
| Product ID | 70720-101_5de36f8a-cbc2-4884-8fcf-e9302d41c2f8 |
| NDC | 70720-101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Varubi |
| Generic Name | Rolapitant |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-10-07 |
| Marketing Category | NDA / NDA |
| Application Number | NDA206500 |
| Labeler Name | TerSera Therapeutics LLC |
| Substance Name | ROLAPITANT HYDROCHLORIDE |
| Active Ingredient Strength | 90 mg/1 |
| Pharm Classes | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-08-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA206500 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-08-06 |
| Ingredient | Strength |
|---|---|
| ROLAPITANT HYDROCHLORIDE | 90 mg/1 |
| SPL SET ID: | a52896cd-4a98-49b8-82db-bf1985a64d97 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 69656-101 | Varubi | rolapitant |
| 69656-102 | Varubi | rolapitant |
| 70720-101 | Varubi | rolapitant |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VARUBI 86591285 4893721 Live/Registered |
Tesaro, Inc. 2015-04-08 |